The Influence of the Exclusion of Central Necrosis on [18F]FDG PET Radiomic Analysis

Autor: Wyanne A. Noortman, Dennis Vriens, Charlotte D. Y. Mooij, Cornelis H. Slump, Erik H. Aarntzen, Anouk van Berkel, Henri J. L. M. Timmers, Johan Bussink, Tineke W. H. Meijer, Lioe-Fee de Geus-Oei, Floris H. P. van Velden

Publikováno v: Diagnostics, Vol 11, Iss 7, p 1296 (2021)

Background: Central necrosis can be detected on [18F]FDG PET/CT as a region with little to no tracer uptake. Currently, there is no consensus regarding the inclusion of regions of central necrosis during volume of interest (VOI) delineation for radio

Externí odkaz: https://doaj.org/article/4a42a7bb126648d3a7e6cfcfb7ce490a

Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective Study

Autor: Christine Do Cao, S. Laboureau, Delphine Drui, Anne-Paule Gimenez-Roqueplo, Isabelle Borget, Martin Schlumberger, Laurence Amar, Patricia Niccoli, Christelle De La Fouchardiere, Henri J L M Timmers, Bruna Calsina, Antongiulio Faggiano, Massimo Mannelli, Eric Baudin, Rossella Libé, Martin Fassnacht, Ségolène Hescot, Felix Beuschlein, Philippe Caron, Delphine Vezzosi, Sophie Leboulleux, Françoise Borson-Chazot, Fernando Riccardi, Timo Deutschbein, Maria Currás-Freixes, Bernard Goichot, Letizia Canu, Antoine Tabarin, Jérôme Bertherat, Anouk van Berkel, Mercedes Robledo, Nuria Valdés

Publikováno v: Journal of Clinical Endocrinology and Metabolism, 104, 2367-2374
Journal of Clinical Endocrinology and Metabolism, 104, 6, pp. 2367-2374

BACKGROUND Malignant pheochromocytoma and paraganglioma (MPP) are characterized by prognostic heterogeneity. Our objective was to look for prognostic parameters of overall survival (OS) in MPP patients. PATIENTS AND METHODS Retrospective multicenter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eebbe5183a0fb5e0d4ab2d273b121e3
https://doi.org/10.1210/jc.2018-01968

The phenotype of SDHB germline mutation carriers

Autor: Johannes A. Rijken, Henricus P. M. Kunst, C. René Leemans, Michiel N. Kerstens, Eleonora P M Corssmit, Alberto M. Pereira, Peter H. Bisschop, Anouk N A van der Horst-Schrivers, Erik F. Hensen, Marieke F. van Dooren, Henri J L M Timmers, Jeroen C. Jansen, Koen M.A. Dreijerink, Karin Eijkelenkamp, Carli M. J. Tops, Frederik J. Hes, Nicolasine D. Niemeijer, Jean-Pierre Bayley, Anouk van Berkel

Publikováno v: European Journal of Endocrinology, 177(2), 115-125. Bioscientifica Ltd
European Journal of Endocrinology, 177, 115-125
European Journal of Endocrinology, 177(2), 115-125. BIOSCIENTIFICA LTD
European Journal of Endocrinology, 177(2), 115-125. BioScientifica Ltd.
European Journal of Endocrinology, 177(2), 115-125
European Journal of Endocrinology, 177, 2, pp. 115-125
Niemeijer, N D, Rijken, J A, Eijkelenkamp, K, Van Der Horst-Schrivers, A N A, Kerstens, M N, Tops, C M J, Van Berkel, A, Timmers, H J L M, Kunst, H P M, Leemans, C R, Bisschop, P H, Dreijerink, K M A, Van Dooren, M F, Bayley, J P, Pereira, A M, Jansen, J C, Hes, F J, Hensen, E F & Corssmit, E P M 2017, ' The phenotype of SDHB germline mutation carriers : A nationwide study ', European Journal of Endocrinology, vol. 177, no. 2, pp. 115-125 . https://doi.org/10.1530/EJE-17-0074
European journal of endocrinology / European Federation of Endocrine Societies, 177(2), 115-125. BioScientifica Ltd.

Objective Succinate dehydrogenase B subunit (SDHB) gene germline mutations predispose to pheochromocytomas, sympathetic paragangliomas, head and neck paragangliomas and non-paraganglionic tumors (e.g. renal cell carcinoma, gastrointestinal stromal tu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22c4950e19d5c9160824f74b98133b9a
https://doi.org/10.1530/EJE-17-0074

Eruption of Metastatic Paraganglioma After Successful Therapy with (177)Lu/(90)Y-DOTATOC and (177)Lu-DOTATATE

Autor: Damian Wild, Corina Millo, Karel Pacak, Marcel J.R. Janssen, Abhishek Jha, Henri J. K. M. Timmers, Melissa K Gonzales, Katherine I. Wolf, Anouk van Berkel, Ingo Janssen

Publikováno v: Nucl Med Mol Imaging

Metastatic paraganglioma treatment options are limited. Peptide receptor radionuclide therapy (PRRT) has been introduced as a novel management option for metastatic neuroendocrine tumors demonstrating safety, efficacy, and increased quality of life.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d57b10410eeb20476d4822d7f195eb47
https://europepmc.org/articles/PMC6554376/

Increased Mortality in

Autor: Johannes A, Rijken, Leonie T, van Hulsteijn, Olaf M, Dekkers, Nicolasine D, Niemeijer, C René, Leemans, Karin, Eijkelenkamp, Anouk N A, van der Horst-Schrivers, Michiel N, Kerstens, Anouk, van Berkel, Henri J L M, Timmers, Henricus P M, Kunst, Peter H L T, Bisschop, Koen M A, Dreijerink, Marieke F, van Dooren, Frederik J, Hes, Jeroen C, Jansen, Eleonora P M, Corssmit, Erik F, Hensen

Publikováno v: Cancers

Germline mutations in succinate dehydrogenase subunit B and D (SDHB and SDHD) are predisposed to hereditary paraganglioma (PGL) and pheochromocytoma (PHEO). The phenotype of pathogenic variants varies according to the causative gene. In this retrospe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e09cded633b6162364debd8ad4c081c0
https://pubmed.ncbi.nlm.nih.gov/30658386